StockData
Eton Pharmaceuticals, Inc. logo

Eton Pharmaceuticals, Inc. (ETON) stock

ETONNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30517% above fair value
$61.99−1.66 (-2.61%)

Close on Nov 18, 2026Market cap $1.77BP/E 158.9Yield –

Eton Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Eton Pharmaceuticals's pe ratio was 175.4× on Nov 11, 2026.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 2026175.4×+85.4
2024Jul 31, 202490.0×+46.2
2023Dec 29, 202343.8×–

More Eton Pharmaceuticals figures

See a number that looks wrong?